Athersys Inc. (Nasdaq: ATHX), a biopharmaceutical company focused on developing an innovative stem cell platform, similar to companies like Mesoblast (MSB: ASX), Osiris (Nasdaq: OSIR) and ThermoGenesis Corp (Nasdaq: KOOL), recently announced that its CEO would deliver the keynote address at the World Stem Cell Summit 2011.
Recent Posts
- ISSCR Unveils Roadmap for Advancing Pluripotent Stem Cell-Derived Therapies
- New gene therapy slows progression of Huntington’s disease by 75%
- Adult Stem Cells Improve Vision in Patients With Macular Degeneration
- Lab-grown kidneys show real function in new stem cell study
- Common Nutrient Found To Supercharge Immune Cells Against Cancer
- Junk DNA” Found to Sense Its Environment, May Hold the Key to Disease Treatment